Status:
COMPLETED
Home Care in Allogeneic Haematopoietic Stem Cell Transplantation
Lead Sponsor:
Oslo University Hospital
Conditions:
Stem Cell Transplant Complications
Quality of Life
Eligibility:
All Genders
18+ years
Brief Summary
Mixed methods study with focus groups interviews and a prospective observational cohort study aimed to investigate the impact of advanced home care on transplant specific outcomes and quality of life ...
Detailed Description
Study of advanced home care after allogeneic haematopoietic stem cell transplantation (allo-HSCT). The main objective is to investigate the impact of home care on transplant specific variables and qua...
Eligibility Criteria
Inclusion
- Consent competency and written informed consent to participation
- Age ≥18
- Understanding and willing to comply with written and oral instructions in Norwegian
- Planned treatment with allo-HSCT
- ECOG performance status 0-2
- Caregiver (age ≥18) present 24 hours a day during the aplastic phase
- Travelling distance from residence to the hospital must be less than one hour.
Exclusion
- Not meeting inclusion criteria
- Uncontrolled infection or other medical condtion unsuitable for out patient care
Key Trial Info
Start Date :
February 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 1 2023
Estimated Enrollment :
16 Patients enrolled
Trial Details
Trial ID
NCT04707417
Start Date
February 1 2022
End Date
August 1 2023
Last Update
November 14 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Haematology, Division of Cancer Medicine, Oslo University Hospital
Oslo, Norway, 0424